Advances in pathogenesis and current therapeutic strategies for cardiorenal syndrome

Area of Science:

• Nephrology
• Cardiology
• Internal Medicine

Background:

• Cardiorenal syndrome (CRS) presents a significant global health challenge due to its complexity and high mortality.
• It involves intricate interactions between the cardiovascular and renal systems.
• Multifactorial mechanisms contribute to CRS, including hemodynamic changes, neurohormonal activation, inflammation, oxidative stress, and metabolic disturbances.

Purpose of the Study:

• To review the current understanding of cardiorenal syndrome (CRS).
• To discuss existing and potential therapeutic strategies for managing CRS.
• To highlight the need for novel treatment approaches.

Main Methods:

• Literature review of cardiorenal syndrome (CRS).
• Analysis of potential therapeutic interventions for CRS.
• Evaluation of current management guidelines and emerging treatments.

Main Results:

• CRS is driven by complex, multifactorial mechanisms.
• Existing treatments like diuretics and RAS inhibitors may offer some benefit.
• Ultrafiltration presents an alternative for fluid management.
• Adenosine receptor antagonists showed no superiority over furosemide.

Conclusions:

• Current management of cardiorenal syndrome (CRS) is deficient.
• Several therapeutic avenues, including diuretics, RAS inhibition, and vitamin D activation, show promise.
• Further research into novel therapeutic approaches is crucial for improving CRS prognosis.